Abstract
Lesions located within the sella and parasellar region of the brain may present with similar clinical symptoms and imaging findings. Anatomic location and key imaging characteristics can aid in the differentiation of these tumors. Major anatomic references within the sella and parasellar region include the pituitary gland, pituitary stalk, optic chiasm, hypothalamus, cavernous sinus, sphenoid sinus, and the meninges. Although the most common tumors located within this region are pituitary adenoma, it is important to consider other less common entities that will also be discussed in this chapter. Normal pituitary may vary in size with gender and age. Premenopausal women tend to have a larger pituitary gland than men and postmenopausal women. Magnetic resonance imaging (MRI) is generally the modality of choice for identification of lesions within this region. There are a few imaging pitfalls and it is important to be aware that nearly 15–20 % of lesions found within the pituitary are asymptomatic incidental findings.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Lesions located within the sella and parasellar region of the brain may present with similar clinical symptoms and imaging findings. Anatomic location and key imaging characteristics can aid in the differentiation of these tumors. Major anatomic references within the sella and parasellar region include the pituitary gland, pituitary stalk, optic chiasm, hypothalamus, cavernous sinus, sphenoid sinus, and the meninges. Although the most common tumors located within this region are pituitary adenoma, it is important to consider other less common entities that will also be discussed in this chapter [1]. Normal pituitary may vary in size with gender and age. Premenopausal women tend to have a larger pituitary gland than men and postmenopausal women [1, 2]. Magnetic resonance imaging (MRI) is generally the modality of choice for identification of lesions within this region. There are a few imaging pitfalls and it is important to be aware that nearly 15–20 % of lesions found within the pituitary are asymptomatic incidental findings [2].
Pituitary Adenoma
Pituitary adenomas are benign tumors of the anterior pituitary that account for 10–15 % of all intracranial tumors [2]. These are the most common suprasellar masses found in adults. The majority occur in middle-aged females, with hyperfunctioning or secreting adenomas more likely to present earlier at a smaller size than nonfunctioning adenomas [3].
Pituitary Microadenoma
A microadenoma is ≤10 mm in diameter. Prolactin-secreting microadenomas are more common in patients 20–35 years old whereas microadenomas that secrete growth hormone are more common in patients 30–50 years old [4].
Microadenomas are commonly visualized as well-defined lesions that enhance less than the normal pituitary gland [4]. Dynamic contrast-enhanced MR may be useful as normal pituitary tissue normally enhances faster than microadenoma. Even when small, microadenomas may cause a mass effect that results in increased convexity of the superior margin of the pituitary gland or contralateral displacement of the infundibulum [4, 5].
Pituitary Macroadenoma
A macroadenoma is larger than 10 mm in diameter [6, 14]. Macroadenomas may cause endocrine symptoms, or visual disturbances due to mass effect upon the optic chiasm or prechiasmatic optic nerves. Management of macroadenoma can vary from medical management to surgical resection, often through a trans-sphenoidal approach [7].
Macroadenomas are expansile masses that often grow superiorly into the suprasellar cistern. When large, they may impinge upon or compress the optic apparatus. Hemorrhagic, proteinaceous, and cystic changes may variably occur. Lateral growth in the cavernous sinus may limit otherwise curative surgical resection of these tumors [5, 6].
Invasive Pituitary Adenoma
Rathke’s Cleft Cyst
Rathke’s cleft cyst (RCC) is a benign cyst that arises from the embryonic Rathke cleft. The cyst may contain a clear or mucoid material. RCCs are usually asymptomatic and are commonly found incidentally upon imaging or autopsy [8]. RCCs are most commonly diagnosed in the fifth decade of life and have a slight female predominance [9]. These cysts typically remain benign and management is usually conservative. If the patient is symptomatic aspiration or partial excision may be necessary.
Most RCCs are visualized as lobulated, well-defined, intrasellar, or suprasellar cysts that contain a small intracystic nodule [8]. More than 50 % of RCCs have a hypointense intracystic nodule upon T2-weighted imaging. RCCs typically do not enhance and rarely contain calcium. Around 40 % of these cysts are located completely within the sella and 60 % have suprasellar extension [9, 12].
Craniopharyngioma
Craniopharyngioma are benign tumors that originate from embryonal cells originating from the Rathke cleft and/or craniopharyngeal duct epithelium [10]. This is the most common intracranial tumor in the pediatric population that is not of glial origin [11]. Craniopharyngiomas account for around half of all sellar tumors that occur in childhood [10]. This tumor type has no gender predominance and occurs in patients age 5–15 years old and patients older than age 50 [11]. Patients may present with visual and/or endocrine disturbances. Prognosis varies with tumor size; tumors with a diameter greater than 5 cm have a worse prognosis than tumors with diameters less than 5 cm [10].
Craniopharyngiomas are typically mixed solid and cystic lesions that contain calcium. Findings on pre-contrast T1-weighted MRI usually show a suprasellar lesion with high signal intensity [12]. These tumors may span to include the anterior, middle, and/or posterior cranial fossa. For surgical purposes, the location of the craniopharyngioma may be described as being sellar, prechiasmatic, or retrochiasmatic. Nonenhanced computed tomography (CT) may be useful to detect the presence of calcium if MR diagnosis is inconclusive [12].
Optic Pathway Glioma
Optic pathway gliomas are responsible for 5 % of all brain tumors. They comprise up to 15 % of supratentorial lesions within the pediatric population [13]. These are usually benign low-grade astrocytomas, although they are difficult to treat because of their location. In 10–20 % or more of patients with optic pathway gliomas, stigmata of neurofibromatosis type 1 are also found [13]. Compared to neurofibromatosis type 1–related tumors, sporadic optic pathway gliomas are more likely to have worse outcomes, impair vision, involve the optic chiasm, extend beyond the optic pathway, have larger size, and cystic nonenhancing components.
Pituitary Hypophysitis
Pituitary hypophysitis or autoimmune hypophysitis is visualized as radiographically similar to nonsecreting adenomas of the pituitary gland [14]. There are two histological subtypes of hypophysitis: lymphocytic and granulomatous [14]. Lymphocytic is the most commonly encountered subtype. Lymphocytic hypophysitis occurs most commonly in the female population with a 1:9 male:female ratio [15]. These lesions are often mistaken for adenomas, and are often diagnosed after subtotal resection and histologic correlation [14]. Pituitary hypophysitis is most commonly seen on MR as a thick, uniformly enhancing infundibulum with or without a pituitary mass lesion [14].
Tuber Cinereum Hamartoma
Tuber cinereum hamartoma is a congenital malformation that can be described as a collection of neurons and glial cells that are located in the tuber cinereum region of the hypothalamus [16]. Tuber cinereum hamartomas are responsible for a third of patients diagnosed with precocious puberty due to excess release of luteinizing hormone-releasing hormone [16, 17]. Although a majority of patients present with symptoms of precocious puberty, seizures are also a common initial presentation. Tuber cinereum hamartoma usually present between the ages of 1 and 3 years old and have no gender predominance [18]. Patients are usually treated medically with hormone suppressants, and surgery is only indicated if medical management fails [16, 18]. Tuber cinereum hamartoma are usually visualized as small, round, nonenhancing lesions on MR and rarely contain cysts or calcium [16].
Langerhans Cell Histiocytosis
Langerhans cell histiocytosis (LCH) is a disease spectrum that evolves as a result of the overproduction of a particular line of dendritic cells that have similar characteristics to Langerhans cells [19]. It is a rapidly progressing disease that can affect virtually any organ within the body and rarely affects the central nervous system (CNS) [19]. The most common CNS manifestation of this disease on MR is a well-circumscribed granuloma located within the sella. Clinical manifestations of this disorder commonly include hormone deficiencies due to invasion of the anterior pituitary [19].
Meningioma
A meningioma is a benign slow-growing lesion that arises from the meninges. Meningioma that occurs in the sella/parasellar region of the brain often occur within the midline in the planum sphenoidale or tuberculum sella region [20]. Patients with these lesions usually present with unilateral loss of visual acuity due to compression of optic structures [20]. Surgical resection is only necessary if clinical symptoms are present. Asymptomatic meningioma should be followed by serial imaging. This lesion is most commonly visualized as a dural-based enhancing lesion with the presence of cortical hyperostosis [20, 21].
References
Johnsen DE, Woodruff WW, Allen IS, et al. MR imaging of the sellar and juxtasellar regions. Radiographics. 1991;11:727–58.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 4–7.
Bronstein MD, Paraiba DB, Jallad RS. Management of pituitary tumors in pregnancy. Nat Rev Endocrinol. 2011;7:301–10.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 20–2.
Cottier JP, Destriex C, Brunereau L, et al. Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology. 2000;215:463–9.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 24–6.
Berkmann S, Fandino J, Zosso S, et al. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. J Neurosurg. 2011;115:518–27.
Byun WB, Kim OL, Kim DS. MR imaging findings of Rathke’s cleft cysts: significance of intracystic nodules. AJNR Am J Neuroradiol. 2000;21:485–8.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 16–8.
Gupta DK, Ojha BK, Sarkar C, et al. Recurrence in craniopharyngiomas: analysis of clinical and histological features. J Clin Neurosci. 2006;13:438–42.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 32–4.
Shin JL, Asa SL, Woodhouse LJ, et al. Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke’s cleft cyst, and arachnoid cyst. J Clin Endocrinol Metabol. 1999;84:3972–82.
Kornreich L, Blaser S, Schwarz M, et al. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol. 2001;22:1963–9.
Gutenberg A, Larsen J, Lupi I, et al. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR Am J Neuroradiol. 2009;30:1766–72.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 40–1.
Saleem SN, Said A-HM, Lee DH. Lesions of the hypothalamus: MR imaging diagnostic features. Radiographics. 2007;27:1087–108.
Arita K, Ikawa F, Kurisu K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J Neurosurg. 1999;91:212–22.
Osborne AG. Sella and pituitary. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 12–4.
Grois N, Prayer D, Prosch H, et al. Neuropathology of CNS disease in Langerhans cell histiocytosis. Brain. 2005;128:829–38.
Massachusetts General Hospital. Tuberculum sellae meningioma. Accessible at: http://neurosurgery.mgh.harvard.edu/cranialbasecenter/c94.htm. Accessed 1 Dec 2011.
Osborne AG. Skull, scalp, and meninges. In: Mascarenaz AD, Dearth CL, Kaerli M, editors. Diagnostic imaging: brain. Salt Lake City: Amirsys; 2005. p. 56–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Patel, G.V., Karimi, S., Young, R.J. (2013). Sellar and Parasellar Masses. In: Karimi, S. (eds) Atlas of Brain and Spine Oncology Imaging. Atlas of Oncology Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5653-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5653-7_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5652-0
Online ISBN: 978-1-4614-5653-7
eBook Packages: MedicineMedicine (R0)